Who Paid My Doc Search
Menu
Product Program year 2020 Source: CMS Open Payments

Cologuard

Device Gastrointestinal

Open in the dashboard

General payments

$2,439,740

164,508 payments

Research payments

$0

0 payments

Through program year 2020, $2,439,740 in general payments and $0 in research payments were reported against Cologuard (Gastrointestinal).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2020 General $1,066,134 56,637
2019 General $1,373,606 107,871

Breakdown

Who paid General payments · program years 2019–2020
  1. Pfizer Inc. $2,435,925 164,261 payments
  2. PBG Puerto Rico LLC $2,060 135 payments
  3. Pfizer Pharmaceuticals LLC $1,739 111 payments
  4. Array BioPharma Inc. $16 1 payment
Top recipients General payments · program year 2020
  1. Brooks Cash Gastroenterology · Houston, TX $14,794 1% · 19 payments
  2. Richard Rachima Family Medicine · Charlotte, NC $13,462 1% · 34 payments
  3. Christopher Alvarado Internal Medicine · Lansing, MI $13,123 1% · 29 payments
  4. David Johnson Gastroenterology · Coeur D Alene, ID $9,003 <1% · 9 payments
  5. Louis Bonavita Family Medicine · East Syracuse, NY $6,851 <1% · 26 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2020.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2020
  1. Family Medicine $525,307 50% · 10,468 practitioners
  2. Internal Medicine $359,670 34% · 6,423 practitioners
  3. Obstetrics & Gynecology $51,451 5% · 1,901 practitioners
  4. Gastroenterology Internal Medicine $33,955 3% · 28 practitioners
  5. General Practice $11,457 1% · 256 practitioners

The top 5 of 103 specialties; each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2020
  1. Texas $92,484 9% · 1,646 recipients
  2. California $83,635 8% · 1,735 recipients
  3. New York $71,408 7% · 1,042 recipients
  4. Florida $63,515 6% · 1,538 recipients
  5. Michigan $60,081 6% · 875 recipients

The top 5 of 52 states; each share is of general payments naming this product in 2020 where a state was reported.

The top 25 states, free in the app

Records

164,508 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record